CTNNB1 and hepatoblastoma: One potential diagnostic pitfall is that malignant rhabdoid tumors may express Glypican-3 [31] and beta catenin [39], proteins that can also be expressed in hepatoblastomas, therefore these markers are not of use in helping to distinguish between these two different tumor types.